Physician profile
Derek Culnan
NPI 1396951620
$8,339.87
in general payments reported to CMS, 2019-2025
25 companies · $4,172 in 2025
The $4,172 reported for 2025 was more than what 91% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,207 · 2020: $37.85 · 2021: $453 · 2022: $1,271 · 2023: $543 · 2024: $657 · 2025: $4,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,500 · Food and Beverage: $1,872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,500.00 |
| Food and Beverage | $1,871.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $4,134.64 | 2023-2025 | Nexobrid, Epicel (Cultured Epidermal Autografts) |
| Access Pro Medical, LLC | $939.34 | 2022-2023 | Matriderm |
| Avita Medical Americas, LLC | $840.21 | 2019-2023 | Recell |
| Smith+Nephew, INC. | $445.67 | 2021-2025 | Collagenase Santyl, Versajet, Acticoat 4" X 4" |
| Mimedx Group, INC. | $275.30 | 2024-2025 | |
| Polarityte, INC. | $247.88 | 2019 | |
| Kerecis Limited | $206.62 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Baxter Healthcare | $179.93 | 2021-2024 | Artiss |
| Medline Industries Lp | $144.80 | 2022 | |
| Acumed LLC | $118.60 | 2024 | Innate Implant, Acumed, Inframe Implant |
| Potrero Medical, INC. | $100.26 | 2021 | |
| Kci USA, INC. | $89.48 | 2020-2023 | V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Molnlycke Health Care US, LLC | $89.44 | 2021 | |
| Polynovo North America LLC | $87.15 | 2019-2023 | |
| Axogen | $84.46 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $78.35 | 2023-2025 | Exparel, Iovera |
| Polymedics Innovations INC. | $74.41 | 2022 | |
| Ovik Health, LLC | $73.00 | 2019 | |
| Tela Bio, INC. | $37.12 | 2019 | |
| Acera Surgical, INC. | $18.90 | 2019 | |
| Abbvie INC. | $18.44 | 2025 | |
| Solventum Corporation | $18.19 | 2025 | Activ.A.C., 3m Cavilon, Promogran Prisma |
| Misonix INC | $16.36 | 2021 | |
| Integra Lifesciences Corporation | $12.80 | 2021 | |
| Medela LLC | $8.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Culnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.